Dr. Yan Yang, MD

Dr. Yang practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Yang's NPI, 1558532184, was assigned on March 24, 2008. Dr. Yang holds Texas license Q1059.

Dr. Yang's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Yang's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Yang is also affiliated with Baylor Scott & White All Saints Medical Center - Fort Worth. The medical group on file is Texas Kidney Consultants. Dmand AI also links Dr. Yang to 3 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Yang is licensed in Texas.

CMS data shows 1,830 Medicare services from Dr. Yang across 11 procedure codes in 2024, for 473 Medicare patients. Medicare paid $200,111 for them.

CMS counts 473 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 4.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 67, with 46% women.

In 2024, Dr. Yang wrote 2,181 Medicare Part D claims for 212 patients. 82% of them were for generic drugs. CMS names the drug for 1,797 of them, across 47 drugs with 11 or more claims each, at $242,390 in total drug cost. In 2023, CMS named 1,547 claims across 44 drugs.

Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Yang, published from 2010 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Exercise, Fibroblasts and Cells, Cultured. Dr. Yang has published most often in Chemistry. Dr. Yang's most frequent co-authors are Yan Yang, MD, Michael D. Tsifansky, MD and Tyler Pearce Martin, DO.

CMS Open Payments shows 84 general payments to Dr. Yang from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $296.